Oropharyngeal cancer

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
4 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
ATC code not specified 1
Mechanism of action (INN-stem analysis)
Platinum compound 2 substances
Macrolide / aminoglycoside 1 substance
Antimetabolite 1 substance
Phase III: 1 Phase II: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • The University Of Birmingham Academic
    IMP not specified
    2024-516108-41-00 1 country 2024 n=24
    Ended

Phase II

1 trial
  • IRCCS Istituto Nazionale Tumori Fondazione Pascale Academic
    BLEOMYCIN SULFATE; CARBOPLATIN; CISPLATIN; FLUOROURACIL
    2025-520735-16-00 1 country n=96
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
IRCCS Istituto Nazionale Tumori Fondazione Pascale Academic 1 Phase II 0
The University Of Birmingham Academic 1 Phase III 0
New trials by year
2024
1
← All indication landscapes